XML 45 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
GENERAL ORGANIZATION AND BUSINESS (Details Narrative) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Nov. 10, 2011
Sep. 30, 2016
Common stock issued to shareholders $ 468,889 $ 31,287    
Accumulated deficit (18,226,179) $ (14,488,655)    
Net cash used in operating activities (1,249,624)      
Cash in hand $ 687,000      
6% Convertible Debt [Member]        
Debt instrument, interest rate 6.00%     6.00%
Boston Therapeutics, Inc. [Member]        
Common stock issued to shareholders     $ 4,000,000  
Percentage of outstanding common stock     100.00%